The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody Ipilimumab in patients with metastatic melanoma who have progressed on anti-PD-1 therapy.
 
Prashanth Prithviraj
No Relationships to Disclose
 
Grant A. McArthur
Research Funding - Celgene; Novartis; Pfizer; Ventana Medical Systems
Travel, Accommodations, Expenses - Merck; Roche Pharma AG
 
Victoria Atkinson
No Relationships to Disclose
 
Phillip Parente
No Relationships to Disclose
 
Miles Cameron Andrews
No Relationships to Disclose
 
Sagun Parakh
No Relationships to Disclose
 
Jonathan S. Cebon
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst)
Research Funding - CSL Behring (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Oliver Klein
No Relationships to Disclose